In this issue:
Humoral immune response to COVID-19 mRNA vaccine in MS patients treated with DMTs
Defining the course of tumefactive MS
Beliefs about medication as predictors of medication adherence in MS
The course of MS in a Norwegian cohort
Axon-myelin unit blistering as early event in MS NAWM
Early factors associated with later conversion to MS in patients presenting with isolated myelitis
Linear brain atrophy measures in MS and CIS
Outcomes and risk factors associated with SARS-CoV-2 infection in MS
Maintenance of natalizumab during the first trimester of pregnancy in active MS
Identifying MS subtypes using unsupervised machine learning and MRI data
Please login below to download this issue (PDF)